HRT Financial LLC bought a new stake in Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,085 shares of the company’s stock, valued at approximately $209,000.

Separately, Citadel Advisors LLC increased its position in Direxion Daily S&P Biotech Bear 3x Shares by 237.2% in the first quarter. Citadel Advisors LLC now owns 14,182 shares of the company’s stock worth $517,000 after buying an additional 9,976 shares in the last quarter.

Shares of LABD opened at $24.72 on Friday. Direxion Daily S&P Biotech Bear 3x Shares has a 52 week low of $21.35 and a 52 week high of $60.30.

See Also: Understanding Relative Strength Index

Want to see what other hedge funds are holding LABD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD)

Receive News & Ratings for Direxion Daily S&P Biotech Bear 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bear 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.